Premium
Retracted : miR‐150 might inhibit cell proliferation and promote cell apoptosis by targeting LMO4 in Burkitt lymphoma
Author(s) -
Zhang Dandan,
Wei Yanshuan,
Zhou Jun,
Wang Guannan,
Xiao Lin,
Xu Jingjing,
Wei Na,
Li Wencai,
Zhang Mingzhi
Publication year - 2019
Publication title -
journal of cellular physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 174
eISSN - 1097-4652
pISSN - 0021-9541
DOI - 10.1002/jcp.27652
Subject(s) - apoptosis , burkitt's lymphoma , cell growth , microbiology and biotechnology , cell , lymphoma , cancer research , biology , immunology , genetics
This study aimed at investigating the effect of microRNA‐150 (miR‐150) on cell proliferation of Burkitt lymphoma and its molecular mechanism. Gene expression analysis was applied to identify target genes of miR‐150 in Burkitt lymphoma cell line ST486 based on the dataset from the Gene Expression Omnibus (GEO) datasets GSE86432. miRNA mimics, inhibitor and small interfering RNA (siRNA) were fluorescently labeled by Cy3, whereas plasmid vector was labeled by EGFP. Cells were viewed by uorescence microscope and transfection efficiency was evaluated through fluorescent cell percentage. Quantitative real‐time polymerase chain reaction analysis (qRT‐PCR) and western blot were applied to detect the expression level of miR‐150 and LMO4 . Cell proliferation, cell cycle, and apoptosis were explored by CCK‐8, flow cytometry. Targeting relationship was validated by the Luciferase reporter assay. Tumor xenograft and immunohistochemical analysis were conducted in nude mice model. In Burkitt lymphoma cells, miR‐150 expression was significantly lower than normal ones, whereas the expression of LMO4 was upregulated. miR‐150 might inhibit cell proliferation and promoted apoptosis in Burkitt lymphoma deterioration by downregulating LMO4 . The results of tumor xenograft further confirmed the role of miR‐150 in Burkitt lymphoma. Targeting LMO4 is a significant mechanism by which miR‐150 suppresses cell growth and promotes apoptosis in Burkitt lymphoma cells, thus may provide a novel target for Burkitt lymphoma therapy in the future.